• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Immune Design

edit

Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence

Recent Milestones

edit

• 
  Immune Design received $32M in Series B funding. (7/26/10)
  Posted 7/26/10 at 6:27pm via xconomy.com
• 
  Immune Design received $18M in Series A funding. (7/7/08)
  Posted 7/26/10 at 6:27pm via xconomy.com
• 
  Immune Design added Bruce Carter as Executive Chairman of the Board.
  Posted 7/26/10 at 6:27pm
• 
  Immune Design added Steven Reed as President and CEO.
  Posted 7/26/10 at 6:27pm
• 
  Immune Design added Thomas Dubensky Jr as CSO.
  Posted 7/26/10 at 6:27pm
• 
  Immune Design added Sammy Farah as Chief Business Officer.
  Posted 7/26/10 at 6:27pm

Videos

Screenshots

edit

Sources

1. Immune Design Aiming To Make Vaccines That Work Better in a Single Shot (xconomy.com) [edit]
2. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]